Deconstructing Schizophrenia: Advances in Preclinical Models for Biomarker Identification.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current topics in behavioral neurosciences

• Publication date

  2018-05-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/7854_2018_48PMID 29721851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic and Imaging Biomarkers in Schizophrenia.

  2018cited by this paper
• Cognitive Phenotypes for Biomarker Identification in Mental Illness: Forward and Reverse Translation.

  2018cited by this paper
• Translational Shifts in Preclinical Models of Depression: Implications for Biomarkers for Improved Treatments.

  2018cited by this paper
• Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

  2018cited by this paper
• Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

  2018cited by this paper
• Network Neuroscience: A Framework for Developing Biomarkers in Psychiatry.

  2018cited by this paper
• Neuroimmune Biomarkers in Mental Illness.

  2018cited by this paper
• Imaging and Genetic Biomarkers Predicting Transition to Psychosis.

  2018cited by this paper
• Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression.

  2017cited by this paper
• Individual prediction of long‐term outcome in adolescents at ultra‐high risk for psychosis: Applying machine learning techniques to brain imaging data

  2017cited by this paper
• Pathway-Specific Dopamine Abnormalities in Schizophrenia.

  2017cited by this paper
• Multimodal investigation of triple network connectivity in patients with 22q11DS and association with executive functions

  2017cited by this paper
• Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes.

  2017cited by this paper
• Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ?

  2017cited by this paper
• The Thalamic Reticular Nucleus in Schizophrenia and Bipolar Disorder: Role of Parvalbumin-Expressing Neuron Networks and Oxidative Stress

  2017cited by this paper
• Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis

  2017cited by this paper
• Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.

  2017cited by this paper
• Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research

  2017cited by this paper
• Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

  2016cited by this paper
• Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

  2016cited by this paper
• Mechanisms of Working Memory Impairment in Schizophrenia

  2016cited by this paper
• A touchscreen based global motion perception task for mice.

  2016cited by this paper
• Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.

  2016cited by this paper
• Effects of a Home-Based Family-Centred Early Habilitation Program on Neurobehavioural Outcomes of Very Preterm Born Infants: A Retrospective Cohort Study

  2016cited by this paper
• Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.

  2016cited by this paper
• Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models

  2016cited by this paper
• Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments.

  2016cited by this paper
• Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: a (1)H MRS study.

  2015cited by this paper
• Functional brain connectivity phenotypes for schizophrenia drug discovery

  2015cited by this paper
• Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls.

  2015cited by this paper
• The thalamic reticular nucleus: A functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery

  2015cited by this paper
• Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?

  2015cited by this paper
• Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity.

  2015cited by this paper
• Brain rhythms connect impaired inhibition to altered cognition in schizophrenia.

  2015cited by this paper
• Developing treatments for cognitive deficits in schizophrenia: The challenge of translation

  2015influential reference
• Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

  2015cited by this paper
• Cognitive course in first-episode psychosis and clinical correlates: A 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.

  2015cited by this paper
• Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank

  2015cited by this paper
• C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications

  2015cited by this paper
• The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies

  2015cited by this paper
• Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.

  2015cited by this paper
• Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities.

  2015cited by this paper
• Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1

  2015cited by this paper
• Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation.

  2015cited by this paper
• Schizophrenia biomarkers: Translating the descriptive into the diagnostic

  2015cited by this paper
• Dysfunctional prefrontal gamma-band oscillations reflect working memory and other cognitive deficits in schizophrenia.

  2015cited by this paper
• Recent genetic findings in schizophrenia and their therapeutic relevance

  2015cited by this paper
• Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.

  2015cited by this paper
• Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia.

  2015cited by this paper
• Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness.

  2014cited by this paper
• Impact of primary negative symptoms on functional outcomes in schizophrenia

  2014cited by this paper
• C-reactive protein levels in schizophrenia: a review and meta-analysis.

  2014cited by this paper
• Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.

  2014cited by this paper
• Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Novel treatment strategies for schizophrenia from improved understanding of genetic risk

  2014cited by this paper
• Clinically meaningful biomarkers for psychosis: a systematic and quantitative review.

  2014cited by this paper
• Schizophrenia Genetics: Building the Foundations of the Future

  2014cited by this paper
• The synapse in schizophrenia

  2014cited by this paper
• Subanesthetic Ketamine Treatment Promotes Abnormal Interactions between Neural Subsystems and Alters the Properties of Functional Brain Networks

  2014cited by this paper
• Mapping Small-World Properties through Development in the Human Brain: Disruption in Schizophrenia

  2014cited by this paper
• Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

  2014cited by this paper
• Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks.

  2014cited by this paper
• Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity

  2013cited by this paper
• Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI

  2013cited by this paper
• owards improved animal models for evaluating social cognition nd its disruption in schizophrenia : The CNTRICS initiative ark

  2013cited by this paper
• Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia.

  2013cited by this paper
• Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain.

  2013cited by this paper
• Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.

  2013cited by this paper
• The θ-γ neural code.

  2013cited by this paper
• Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research.

  2013cited by this paper
• CNTRICS final animal model task selection: control of attention.

  2013cited by this paper
• Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies

  2013cited by this paper
• The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?

  2013cited by this paper
• The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia

  2013cited by this paper
• Dysconnectivity in the Frontoparietal Attention Network in Schizophrenia

  2013cited by this paper
• Animal models and measures of perceptual processing in schizophrenia.

  2013cited by this paper
• Abnormal effective connectivity in the psychosis high-risk state

  2013cited by this paper
• DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity.

  2013cited by this paper
• Disruption of prefrontal cortical-hippocampal balance in a developmental model of schizophrenia: reversal by sulpiride.

  2013cited by this paper
• The touchscreen operant platform for testing working memory and pattern separation in rats and mice

  2013cited by this paper
• Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems.

  2013cited by this paper
• Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

  2012cited by this paper
• Brain rhythms and neural syntax: implications for efficient coding of cognitive content and neuropsychiatric disease.

  2012cited by this paper
• NMDA receptors, cognition and schizophrenia--testing the validity of the NMDA receptor hypofunction hypothesis.

  2012cited by this paper
• Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia.

  2012cited by this paper
• Decoupling of Sleep-Dependent Cortical and Hippocampal Interactions in a Neurodevelopmental Model of Schizophrenia

  2012cited by this paper
• New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.

  2012cited by this paper
• The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia

  2012cited by this paper
• Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

  2012cited by this paper
• Reduced Prefrontal-Parietal Effective Connectivity and Working Memory Deficits in Schizophrenia

  2012cited by this paper
• Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity.

  2012cited by this paper
• Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap

  2012cited by this paper
• Animal model for schizophrenia that reflects gene-environment interactions.

  2011cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

  2011cited by this paper
• Animal models of schizophrenia

  2011cited by this paper
• A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory

  2011cited by this paper
• Multiple origins of the cortical gamma rhythm

  2011cited by this paper
• Altered functional and anatomical connectivity in schizophrenia.

  2011cited by this paper

• Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia.

  2026cites this paper
• Deconstruction in Psychiatry: Are We Missing the Forest for the Trees?

  2025cites this paper
• Maximising translational value of the Iowa gambling task in preclinical studies through the use of the rodent touchscreen

  2025cites this paper
• Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis

  2025cites this paper
• A Thalamocortical Perspective on Sleep Spindle Alterations in Neurodevelopmental Disorders

  2024cites this paper
• Muscarinic receptor agonists in animal models of psychosis: protocol for a systematic review and meta-analysis

  2024cites this paper
• Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.

  2023cites this paper
• Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia

  2023cites this paper
• A consideration of the increased risk of schizophrenia due to prenatal maternal stress, and the possible role of microglia.

  2023cites this paper
• Abnormality of subcortical volume and resting functional connectivity in adolescents with early-onset and prodromal schizophrenia.

  2021cites this paper
• Impaired working memory, cognitive flexibility and reward processing in mice genetically lacking Gpr88: Evidence for a key role for Gpr88 in multiple cortico‐striatal‐thalamic circuits

  2020cites this paper
• Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system – implications for the 3Rs and preclinical drug discovery

  2020cites this paper
• 16p11 Duplication Disrupts Hippocampal-Orbitofrontal-Amygdala Connectivity, Revealing a Neural Circuit Endophenotype for Schizophrenia.

  2020cites this paper
• Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models

  2020cites this paper
• Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia

  2019cites this paper
• Multivariate patterns of gray matter volume in thalamic nuclei are associated with positive schizotypy in healthy individuals

  2019cites this paper
• Stem Cells to Inform the Neurobiology of Mental Illness.

  2018cites this paper
• Prefrontal cortex modulates firing pattern in the nucleus reuniens of the midline thalamus via distinct corticothalamic pathways

  2018cites this paper
• Biomarkers in Neuropsychiatry: A Prospect for the Twenty-First Century?

  2018cites this paper